Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus
نویسندگان
چکیده
منابع مشابه
Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
The emerging arthritogenic, mosquito-borne chikungunya virus (CHIKV) causes severe disease in humans and represents a serious public health threat in countries where Aedes spp mosquitoes are present. This study describes for the first time the successful production of CHIKV virus-like particles (VLPs) in insect cells using recombinant baculoviruses. This well-established expression system is ra...
متن کاملZika virus-like particle (VLP) based vaccine
The newly emerged mosquito-borne Zika virus poses a major public challenge due to its ability to cause significant birth defects and neurological disorders. The impact of sexual transmission is unclear but raises further concerns about virus dissemination. No specific treatment or vaccine is currently available, thus the development of a safe and effective vaccine is paramount. Here we describe...
متن کاملInactivated Whole Virus Influenza A (H5N1) Vaccine1
To the Editor: Avian infl uenza viruses of the H5N1 subtype represent a potential source of the next pandemic (1,2). Our goal was to determine the safety and immunogenicity of a newly developed vaccine in humans. The vaccine was produced by the same method as the interpandemic in-fl uenza vaccine " FluvalAB " used in Hungary for the past 11 years (3,4). The method has been validated by meeting ...
متن کاملComparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
Four vaccines for feline leukemia virus (FeLV) are available in the United States. This study's purpose was to compare the efficacy of Nobivac feline 2-FeLV (an inactivated, adjuvanted whole-virus vaccine) and PureVax recombinant FeLV (a live, canarypox virus-vectored vaccine) following FeLV challenge. Cats were vaccinated at 9 and 12 weeks with Nobivac feline 2-FeLV (group A, n = 11) or PureVa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Infectious Diseases
سال: 2016
ISSN: 0022-1899,1537-6613
DOI: 10.1093/infdis/jiw352